S T A T E O F N E W Y O R K
________________________________________________________________________
9634
I N A S S E M B L Y
January 28, 2020
___________
Introduced by M. of A. L. ROSENTHAL, QUART, RICHARDSON, CARROLL, WEPRIN,
SIMON, GOTTFRIED, HEVESI -- read once and referred to the Committee on
Health
AN ACT to amend the social services law and the public health law, in
relation to medication for the treatment of substance use disorders
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Subdivision 2 of section 365-a of the social services law
is amended by adding a new paragraph (gg) to read as follows:
(GG) ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE
NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE
USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFES-
SIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER. SUCH
MEDICATION ASSISTED TREATMENT SHALL NOT BE SUBJECT TO ANY PRIOR AUTHORI-
ZATION MANDATE.
§ 2. Subdivision 26-b of section 364-j of the social services law, as
added by section 4 of part B of chapter 69 of the laws of 2016, is
amended to read as follows:
26-b. Managed care providers shall not require prior authorization for
[an initial or renewal prescription for buprenorphine or injectable
naltrexone for detoxification or maintenance treatment of opioid
addiction unless the prescription is for a non-preferred or non-formu-
lary form of the drug or as otherwise required by section 1927(k)(6) of
the Social Security Act] ANY BUPRENORPHINE PRODUCTS, METHADONE OR LONG
ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT
OF A SUBSTANCE USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED
NATIONAL PROFESSIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE
DISORDER.
§ 3. Subdivision 10 of section 273 of the public health law, as added
by section 5 of part B of chapter 69 of the laws of 2016, is amended to
read as follows:
10. Prior authorization shall not be required for [an initial or
renewal prescription for buprenorphine or injectable naltrexone for
detoxification or maintenance treatment of opioid addiction unless the
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD10713-07-0
A. 9634 2
prescription is for a non-preferred or non-formulary form of such drug
as otherwise required by section 1927(k)(6) of the Social Security Act]
ANY BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREX-
ONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE
DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFES-
SIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER.
§ 4. This act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that the amendments to subdivision
26-b of section 364-j of the social services law made by section two of
this act shall not affect the repeal of such section, and shall be
deemed repealed therewith.